Fox Chase Cancer Center, Sylvester Comprehensive Cancer Center, and Pfizer’s Institute of Translational Equitable Medicine formed a collaboration to launch a cancer genomics study to characterize novel genetic, molecular, and social determinants of cancer across populations of African ancestry.
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).
